Aldeyra Therapeutics, Inc.
NASDAQ:ALDX · NASDAQ Capital Market
+$0.06 today
Vol 2.18M · Avg 2.13M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-36.57%
Period High
$5.89
Period Low
$1.24
Latest
$1.96
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alto Neuroscience, Inc.
NYSE:ANRO
$787.86M
Candel Therapeutics, Inc.
NASDAQ:CADL
$448.72M
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$443.22M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$348.62M
Amarin Corporation plc
NASDAQ:AMRN
$334.13M
Silence Therapeutics plc
NASDAQ:SLN
$321.19M
Cellectis S.A.
NASDAQ:CLLS
$308.78M
AC Immune S.A.
NASDAQ:ACIU
$242.73M
Genelux Corporation
NASDAQ:GNLX
$110.03M
Mereo BioPharma Group plc
NASDAQ:MREO
$50.69M
What is the latest ALDX filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does ALDX have?
Intrinsic Alpha currently shows 20 recent filings for ALDX.
Explore More
Continue the stock analysis
Jump to another research area for this company.